Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: atorvastatin attending: chief complaint: bilateral lower extremity edema major surgical or invasive procedure: none history of present illness: 60 yo female discharged to rehab after avr/root enlargement/mvr/cabg x1 on . presented to emergency room from rehab after le edema noted. past medical history: hypertension hypercholesterolemia severe aortic stenosis mild mitral stenosis osteopenia arthritis asthma breast papilloma depression atrial fibrillation psh: s/p avr (tissue)/aortic root enlargement/mvr/cabg x1 oopherectomy breast cyst excision c-section bilateral carpal tunnel release l trigger finger release social history: receptionist tobbaco: 30 pack year history/quit 30 years ago etoh: denies lives with husband family history: father died of sudden death @37 years old physical exam: pulse: 71 resp:18 o2 sat: 95%-ra b/p right: 108/70 left: height: weight: general: skin: dry intact heent: perrla eomi neck: supple full rom chest: lungs clear bilaterally heart: rrr irregular murmur sternum: stable, incision cdi abdomen: soft non-distended non-tender bowel sounds + extremities: warm , well-perfused edema: 2+ varicosities: none rt side evh site with echymosis and small instrumentation site with serous drainage neuro: grossly intact pulses: femoral right: 2+ left:2+ dp right: 2+ left:2+ pt : 2+ left:2+ radial right: 2+ left:2+ carotid bruit right: none left: none pertinent results: 05:40am blood wbc-16.9* rbc-3.24* hgb-9.7* hct-30.0* mcv-93 mch-30.1 mchc-32.4 rdw-16.7* plt ct-398 03:10pm blood neuts-81.4* lymphs-10.8* monos-5.3 eos-2.2 baso-0.3 05:40am blood plt ct-398 03:10pm blood pt-14.1* ptt-26.3 inr(pt)-1.2* ******************* 09:33am blood wbc-15.5* rbc-3.51* hgb-10.5* hct-33.1* mcv-94 mch-29.8 mchc-31.7 rdw-16.4* plt ct-439 09:33am blood plt ct-439 05:55am blood urean-21* creat-1.0 na-139 k-3.9 cl-99 hco3-26 angap-18 le duplex impression: no evidence of deep venous thrombosis in the lower extremities bilaterally. the study and the report were reviewed by the staff radiologist. dr. dr. dr. approved: tue 1:05 am echocardiography report , tte (complete) done at 3:44:10 pm final referring physician information , division of cardiothoracic , status: inpatient dob: age (years): 60 f hgt (in): 60 bp (mm hg): 90/68 wgt (lb): 260 hr (bpm): 75 bsa (m2): 2.09 m2 indication: aortic valve disease. h/o cardiac surgery. mitral valve disease. 21 mm c-e aortic valve and 25 mm mosaic mitral valve. icd-9 codes: 402.90, v42.2, 424.1, 424.0 test information date/time: at 15:44 interpret md: , md test type: tte (complete) son: . , rdcs doppler: full doppler and color doppler test location: west echo lab contrast: none tech quality: adequate tape #: 2009w011-0:20 machine: vivid echocardiographic measurements results measurements normal range left atrium - long axis dimension: *5.2 cm <= 4.0 cm left atrium - four chamber length: *6.3 cm <= 5.2 cm right atrium - four chamber length: *5.9 cm <= 5.0 cm left ventricle - septal wall thickness: *1.3 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: *1.3 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 4.9 cm <= 5.6 cm left ventricle - systolic dimension: 3.6 cm left ventricle - fractional shortening: *0.27 >= 0.29 left ventricle - ejection fraction: 50% to 55% >= 55% aorta - sinus level: 2.6 cm <= 3.6 cm aorta - ascending: 2.2 cm <= 3.4 cm aorta - arch: 2.6 cm <= 3.0 cm aortic valve - peak gradient: *27 mm hg < 20 mm hg aortic valve - mean gradient: 14 mm hg mitral valve - mean gradient: 7 mm hg mitral valve - pressure half time: 117 ms mitral valve - e wave: 2.1 m/sec mitral valve - a wave: 1.2 m/sec mitral valve - e/a ratio: 1.75 mitral valve - e wave deceleration time: *304 ms 140-250 ms tr gradient (+ ra = pasp): *42 mm hg <= 25 mm hg findings at one year the mean reported gradient for 25 mm mosaic valve was 6.7 +/- 1.7. left atrium: marked la enlargement. left ventricle: mild symmetric lvh. mildly depressed lvef. no resting lvot gradient. right ventricle: dilated rv cavity. normal rv systolic function. . aorta: normal aortic diameter at the sinus level. normal ascending aorta diameter. normal aortic arch diameter. aortic valve: bioprosthetic aortic valve prosthesis (avr). normal avr gradient. mitral valve: bioprosthetic mitral valve prosthesis (mvr). normal mvr gradient. tricuspid valve: moderate to severe tr. moderate pa systolic hypertension. pulmonic valve/pulmonary artery: no ps. pericardium: no pericardial effusion. conclusions the left atrium is markedly dilated. there is mild symmetric left ventricular hypertrophy. overall left ventricular systolic function is mildly depressed (lvef= 50-55 %). the right ventricular cavity is dilated with normal free wall contractility. a bioprosthetic aortic valve prosthesis is present and appears well seated. the transaortic gradient is normal for this prosthesis. a bioprosthetic mitral valve prosthesis is present and appears well seated. the leaflets were not well visualized. the transmitral gradient is normal for this prosthesis. moderate to severe tricuspid regurgitation is seen. there is moderate pulmonary artery systolic hypertension. there is no pericardial effusion. electronically signed by , md, interpreting physician 16:29 , f 60 radiology report chest (pa & lat) study date of 4:42 pm , eu 4:42 pm chest (pa & lat) clip # reason: eval for dvt medical condition: 60 year old woman sp cabg who presents with increased bilateral lower extremity swelling. reason for this examination: eval for dvt final report history: 60-year-old patient, status post cabg, who presents with increased bilateral lower extremity swelling, to assess for a cardiopulmonary process. technique: ap and lateral radiographs of the chest were performed. comparison is made with prior radiograph dated . findings: the patient is status post sternotomy. the heart remains enlarged. a valvular cardiac prosthesis is unchanged. atelectasis and a small right basal effusion are unchanged. the left basal effusion has decreased. linear atelectasis is present in the left mid zone as well as right mid zone. there is no focal pulmonary consolidation. conclusion: atelectasis in mid zones bilaterally and right lung base with a persistent right basal effusion. interval improvement with decrease in the left basal effusion. the study and the report were reviewed by the staff radiologist. dr. dr. approved: tue 1:07 am brief hospital course: ms was readmitted for iv diuresis. her emergency room workup was negative for dvt by us and cxr showed cardiomegaly small bilateral effusions and associated atelectasis. her troponin was elevated but her cpk was normal at that time, her ekg was unremarkable. she was agressively diuresed during her hospital stay. she worked with physical therapy and was discharged home with visiting nurses on hd# 4. medications on admission: medications at discharge to rehab: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 3. fluoxetine 20 mg capsule sig: two (2) capsule po daily (daily). 4. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) puff inhalation (2 times a day). 5. rosuvastatin 5 mg tablet sig: one (1) tablet po daily (daily). 6. amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day): 400mg x 1 wk then 400mg qd x1 wk then 200mg qd. 7. insulin lispro 100 unit/ml solution sig: sliding scale subcutaneous qac&hs. 8. bisacodyl 10 mg suppository sig: one (1) suppository rectal daily (daily) as needed for constipation. 9. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po hs (at bedtime) as needed for constipation. 10. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 11. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed for pain. 12. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) neb inhalation q6h (every 6 hours). 13. ipratropium bromide 0.02 % solution sig: one (1) neb inhalation q6h (every 6 hours). 14. tramadol 50 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. 15. metoprolol tartrate 25 mg tablet sig: 1.5 tablets po tid (3 times a day). 16. potassium chloride 10 meq capsule, sustained release sig: four (4) capsule, sustained release po bid (2 times a day). 17. cephalexin 500 mg capsule sig: one (1) capsule po q8h (every 8 hours) for 7 days. 18. furosemide 10 mg/ml solution sig: forty (40) mg injection (2 times a day) for 1 weeks: then convert to po dosing. meds at rehab: fish oil, mvi, asa 81', kcl 10', norvasc 10', loratidine 10', fluoxetine 40', advair 1 puff qs, pravastatin 10', amiodarone 400', oxycodone 5-15mg q3/prn, lasix 40'(po), zantac 150', atrovent, albuterol, tramadol 50 q6-8/prn, metoprolol 25/tid, keflex 500 tid, allergies: atorvastatin discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 2 weeks. 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. fluoxetine 20 mg capsule sig: two (2) capsule po daily (daily). 4. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). disp:*1 disk with device(s)* refills:*2* 5. pravastatin 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily) for 2 weeks. disp:*30 tablet(s)* refills:*0* 7. tramadol 50 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 8. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*2* 9. amiodarone 200 mg tablet sig: two (2) tablet po daily (daily) for 6 days: 400 mg daily until ; then 200 mg daily starting . 10. metolazone 2.5 mg tablet sig: two (2) tablet po daily (daily) for 2 weeks: take 1/2 hour before lasix will assess need for futher dosing at follow up. disp:*7 tablet(s)* refills:*1* 11. furosemide 40 mg tablet sig: one (1) tablet po daily (daily) for 2 weeks: will eval if you need further dosing at follow up. disp:*14 tablet(s)* refills:*1* 12. potassium chloride 20 meq tab sust.rel. particle/crystal sig: two (2) tab sust.rel. particle/crystal po once a day for 2 weeks: continue this medication as long as you are on lasix. disp:*28 tab sust.rel. particle/crystal(s)* refills:*1* 13. amiodarone 200 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* discharge disposition: home with service facility: vna discharge diagnosis: hypertension hypercholesterolemia severe aortic stenosis mild mitral stenosis osteopenia arthritis asthma breast papilloma depression atrial fibrillation psh: s/p avr (tissue)/aortic root enlargement/mvr/cabg x1 oopherectomy breast cyst excision c-section bilateral carpal tunnel release l trigger finger release discharge condition: stable discharge instructions: no lotions, creams or powders on any incision shower daily and pat incision dry call for fever greater than 100,redness, drainage, or weight gain of 2 pounds in 2 days or 5 pounds in one week no driving for one month no lifting greater than 10 pounds for another 8 weeks wear your surgical bra all day every day even when sleeping. you may have it off for one hour per day. followup instructions: call and schedule the following appointments: dr. in weeks dr. on at 11:00am dr. in 4 weeks echocardiogram phone: date/time: 10:00am md procedure: extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery open and other replacement of aortic valve with tissue graft open and other replacement of mitral valve with tissue graft repair of blood vessel with tissue patch graft diagnoses: other iatrogenic hypotension thrombocytopenia, unspecified anemia, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension atrial fibrillation asthma, unspecified type, unspecified personal history of tobacco use depressive disorder, not elsewhere classified pulmonary collapse other and unspecified hyperlipidemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mitral valve insufficiency and aortic valve stenosis disorder of bone and cartilage, unspecified arthropathy, unspecified, site unspecified edema 

Answer: The patient is high likely exposed to